Fecha: Sábado 25 de septiembre

Hora: 10:00 am

Presenta: Dr. Cristian Tabilo

Tema: Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial.

Ver paper